We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
Cap. Flow
-$214M
Cap. Flow %
-13.95%
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Consumer Discretionary 11.71%
3 Healthcare 9.05%
4 Industrials 8.79%
5 Financials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELVN icon
1001
Enliven Therapeutics
ELVN
$4.43B
$26.8K ﹤0.01%
33,550
-512
-2% -$10.3K
PYXS icon
1002
Pyxis Oncology
PYXS
$236M
$26.5K ﹤0.01%
+10,352
New +$32.8K
DFLI icon
1003
Dragonfly Energy
DFLI
$18.9M
$25.5K ﹤0.01%
+191
New +$56.9K
KORE
1004
DELISTED
KORE Group Holdings
KORE
$24K ﹤0.01%
+3,931
New +$26K
ADAP
1005
DELISTED
Adaptimmune Therapeutics
ADAP
$23.3K ﹤0.01%
+25,181
New +$30K
STLN
1006
Starling Oncology, Inc. Common Stock
STLN
$641M
$22.7K ﹤0.01%
+41,217
New +$21.8K
YOTAR
1007
DELISTED
Yotta Acquisition Corporation Right
YOTAR
$18.5K ﹤0.01%
100,000
POL.WS
1008
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$15.8K ﹤0.01%
243,608
NFYS.WS
1009
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$15.3K ﹤0.01%
306,250
ASTLW icon
1010
Algoma Steel Group Warrant
ASTLW
$14.9K ﹤0.01%
12,313
DISAW
1011
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$14.6K ﹤0.01%
158,499
SNDL icon
1012
CALL
Sundial Growers
SNDL
$320M
$14.2K ﹤0.01%
10,400
AAC.WS
1013
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$13.6K ﹤0.01%
16,967
-42,500
-71% -$29.7K
FXLV
1014
DELISTED
F45 Training Holdings Inc.
FXLV
$13.5K ﹤0.01%
26,922
VANI icon
1015
Vivani Medical
VANI
$122M
$13.3K ﹤0.01%
10,996
RENEW
1016
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$12.8K ﹤0.01%
81,500
CPUH.WS
1017
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$12.6K ﹤0.01%
25,179
PSNYW icon
1018
Polestar Automotive Holding ADS Class C-1
PSNYW
$387M
$11.4K ﹤0.01%
551
ARIZR
1019
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$11.3K ﹤0.01%
140,000
GHIXW
1020
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$11.1K ﹤0.01%
65,440
-279,983
-81% -$54.9K
RMGCW
1021
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$11K ﹤0.01%
100,230
GBBKR
1022
DELISTED
Global Blockchain Acquisition Corp. Right
GBBKR
$11K ﹤0.01%
100,000
AMPX.WS icon
1023
Amprius Technologies Warrants
AMPX.WS
$556M
$10.8K ﹤0.01%
22,500
RWODR
1024
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
$10.8K ﹤0.01%
60,000
MSSAR
1025
DELISTED
Metal Sky Star Acquisition Corporation Right
MSSAR
$10.2K ﹤0.01%
60,000

Similar funds

Prelude Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.

  • Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
  • Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
  • Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
  • Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
  • Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
  • Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.